Sadik H. Kassim

6.1k total citations · 1 hit paper
28 papers, 1.5k citations indexed

About

Sadik H. Kassim is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Sadik H. Kassim has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Sadik H. Kassim's work include CAR-T cell therapy research (13 papers), Virus-based gene therapy research (9 papers) and CRISPR and Genetic Engineering (9 papers). Sadik H. Kassim is often cited by papers focused on CAR-T cell therapy research (13 papers), Virus-based gene therapy research (9 papers) and CRISPR and Genetic Engineering (9 papers). Sadik H. Kassim collaborates with scholars based in United States, France and Uganda. Sadik H. Kassim's co-authors include Mark E. Dudley, Steven A. Feldman, Marybeth S. Hughes, Richard M. Sherry, Steven A. Rosenberg, Udai S. Kammula, Nicholas P. Restifo, Stephen R. Jennings, Mark Raffeld and Jessica S. Crystal and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sadik H. Kassim

27 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

2014 585 citations Paul F. Robbins, Sadik H. Kassim et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sadik H. Kassim United States	13	956	836	391	319	191	28	1.5k
Lien T. Ngo United States	16	1.2k 1.3×	1.1k 1.3×	569 1.5×	246 0.8×	118 0.6×	19	2.0k
Karin Schreiber United States	19	544 0.6×	582 0.7×	218 0.6×	94 0.3×	73 0.4×	43	1.1k
Francesca Del Bufalo Italy	20	478 0.5×	269 0.3×	330 0.8×	182 0.6×	163 0.9×	78	1.2k
Keith Kerstann United States	8	1.4k 1.5×	1.6k 1.9×	448 1.1×	319 1.0×	134 0.7×	9	2.1k
Tatiana N. Golovina United States	18	604 0.6×	1.3k 1.6×	445 1.1×	174 0.5×	79 0.4×	21	1.8k
Yuriko Fujita Japan	7	1.0k 1.1×	418 0.5×	465 1.2×	450 1.4×	277 1.5×	19	1.3k
Debattama R. Sen United States	13	1.4k 1.4×	1.9k 2.3×	574 1.5×	121 0.4×	89 0.5×	20	2.5k
Dass S. Vinay United States	24	797 0.8×	1.7k 2.1×	302 0.8×	126 0.4×	29 0.2×	44	2.3k
Caroline Raffin France	8	360 0.4×	672 0.8×	157 0.4×	99 0.3×	78 0.4×	10	963

Countries citing papers authored by Sadik H. Kassim

Since Specialization

Citations

This map shows the geographic impact of Sadik H. Kassim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadik H. Kassim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadik H. Kassim more than expected).

Fields of papers citing papers by Sadik H. Kassim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sadik H. Kassim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadik H. Kassim. The network helps show where Sadik H. Kassim may publish in the future.

Co-authorship network of co-authors of Sadik H. Kassim

This figure shows the co-authorship network connecting the top 25 collaborators of Sadik H. Kassim. A scholar is included among the top collaborators of Sadik H. Kassim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sadik H. Kassim. Sadik H. Kassim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Urnov, Fyodor D., Sadik H. Kassim, Kiran Musunuru, et al.. (2025). Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and Danaher. Cytotherapy. 27(10). 1151–1163. 2 indexed citations

Kassim, Sadik H., Fyodor D. Urnov, Kiran Musunuru, et al.. (2025). Platform solutions for commercial challenges to expanding patient access and making gene editing sustainable. Nature Biotechnology. 43(7). 1047–1049. 2 indexed citations

Brooks, Philip J., Timothy M. Miller, Frédéric Revah, et al.. (2024). The Bespoke Gene Therapy Consortium: facilitating development of AAV gene therapies for rare diseases. Nature Reviews Drug Discovery. 23(3). 157–158. 13 indexed citations

Li, Matthew, et al.. (2022). Development and Clinical Translation Considerations for the Next Wave of Gene Modified Hematopoietic Stem and Progenitor Cells Therapies. Expert Opinion on Biological Therapy. 22(9). 1177–1191. 2 indexed citations

Kassim, Sadik H., et al.. (2021). Evaluation of Newly Released Cassava Varieties for Yield Performance, Reactions to Cassava Diseases and Farmers’ Preference in Adjumani District of Uganda. Journal of Agricultural Science. 13(4). 84–84. 4 indexed citations

Kassim, Sadik H., et al.. (2021). 115 An NFAT promoter based fluorescent Jurkat cell platform for high-throughput screening of chimeric antigen receptor (CAR) constructs. SHILAP Revista de lepidopterología. A124–A124. 1 indexed citations

Xue, Qiong, Emily Bettini, Patrick Paczkowski, et al.. (2017). Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response. Journal for ImmunoTherapy of Cancer. 5(1). 85–85. 92 indexed citations

Kassim, Sadik H.. (2017). Toward an integrated model of product characterization for CAR-T cell therapy drug development efforts. Cell and Gene Therapy Insights. 3(4). 227–237. 12 indexed citations

Zhang, Ling, Richard A. Morgan, Joal D. Beane, et al.. (2015). Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma. Clinical Cancer Research. 21(10). 2278–2288. 332 indexed citations

10.

Tran, Thai H., Reshma Singh, Jennifer Bordeaux, et al.. (2015). Quantitative Multiplexed Immunohistochemistry Assays for Exploring CAR Modified T Cells and Checkpoint Inhibitors in Lymphoma Trials. Blood. 126(23). 2659–2659. 2 indexed citations

11.

Robbins, Paul F., Sadik H. Kassim, Thai L.N. Tran, et al.. (2014). A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response. Clinical Cancer Research. 21(5). 1019–1027. 585 indexed citations breakdown →

12.

Chen, Shu‐Jen, Julio Sanmiguel, Martin Lock, et al.. (2013). Biodistribution of AAV8 Vectors Expressing Human Low-Density Lipoprotein Receptor in a Mouse Model of Homozygous Familial Hypercholesterolemia. PubMed. 24(4). 154–160. 31 indexed citations

13.

Kassim, Sadik H. & Robert Somerville. (2013). From Lipoproteins to Chondrocytes: A Brief Summary of the European Medicines Agency's Regulatory Guidelines for Advanced Therapy Medicinal Products. Human Gene Therapy. 24(6). 568–570. 3 indexed citations

14.

Kassim, Sadik H., et al.. (2013). Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells. Cellular Immunology. 284(1-2). 119–128. 6 indexed citations

15.

Kochenderfer, James N., Mark E. Dudley, Sadik H. Kassim, et al.. (2013). Effective Treatment Of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma With Autologous T Cells Genetically-Engineered To Express An Anti-CD19 Chimeric Antigen Receptor. Blood. 122(21). 168–168. 8 indexed citations

16.

Kassim, Sadik H., Hui Li, Peter Bell, et al.. (2012). Adeno-Associated Virus Serotype 8 Gene Therapy Leads to Significant Lowering of Plasma Cholesterol Levels in Humanized Mouse Models of Homozygous and Heterozygous Familial Hypercholesterolemia. Human Gene Therapy. 24(1). 19–26. 57 indexed citations

17.

Kassim, Sadik H., et al.. (2011). Identification and functional characterization in vivo of a novel splice variant of LDLR in rhesus macaques. Physiological Genomics. 43(15). 911–916. 3 indexed citations

18.

Kassim, Sadik H., Hui Li, Luk H. Vandenberghe, et al.. (2010). Gene Therapy in a Humanized Mouse Model of Familial Hypercholesterolemia Leads to Marked Regression of Atherosclerosis. PLoS ONE. 5(10). e13424–e13424. 62 indexed citations

19.

Kassim, Sadik H., Naveen K. Rajasagi, Barry W. Ritz, et al.. (2009). Dendritic Cells Are Required for Optimal Activation of Natural Killer Functions following Primary Infection with Herpes Simplex Virus Type 1. Journal of Virology. 83(7). 3175–3186. 30 indexed citations

20.

Nogusa, Shoko, Barry W. Ritz, Sadik H. Kassim, Stephen R. Jennings, & Elizabeth M. Gardner. (2008). Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mechanisms of Ageing and Development. 129(4). 223–230. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact